GMP Biologics Market to Reach US$98.2 Bn by 2033 Accelerates with Biopharmaceutical Innovation - Persistence Market Research

Positive

AI Analysis

Summary

Persistence Market Research projects the global GMP biologics market will grow from US$52.7 billion in 2026 to US$98.2 billion by 2033, driven by rising biopharmaceutical innovation demand.

Financial Highlights

Revenue

US$52.7 billion (2026), US$98.2 billion (2033)

Guidance

CAGR of 9.3% during forecast period

Importance:2/10

Sentiment:

0.50

GMP biologicsmarket analysisbiopharmaceuticalmarket growth

Related Companies

$IPIX $GBCYD

Read the original article

Published by PR Newswire Biotech on July 29, 2026 5:14 PM

Read Original